“…The possible involvement of endogenous GABA in peristalsis was evaluated after suppression of GABA function by SR 95531, a novel competitive GABAA-receptor antagonist (Wermuth & Biziere, 1986;Tonini et al, 1989), or picrotoxinin (a blocker of the chloride channel associated with GABAA-receptors; Krantis & Kerr, 1981b), and in the presence of the non-specific GABAB-receptor antagonist D-aminovaleric acid (DAVA) (Muhyaddin et al, 1982;Ong & Kerr, 1987;Dickenson et al, 1988) (100pM) were also performed in the absence and in the presence of 10min exposure to the antagonists hyoscine, TTX, picrotoxinin and SR 95531. Any drug-induced change in 3-APS response was expressed as a % change with respect to the agonist basal response.…”